Corporate & Background
 Custom Manufacturing
 Business & Products
 Facilities & Strengths
Manufacturing
Unit 1 | Hyderabad
Pilot Plant
Production Blocks
Services
Unit 2 | Visakhapatnam
Special Reaction Blocks
Separations
Strengths
 Ethics & Values
 Regulatory Submissions
 Investors & Financials
 Careers
 Locations & Contact
 Media Center
 Enquiry
 Home
     Our Nutraceuticals website
      News & Events

 Divi’s Labs earns a PAT of Rs.129 crores for Q4
 Divi’s Labs earns an Income of Rs.649 crores for 9M of FY10
 Divis Labs earns an Income of Rs.445 crores in H1 of FY10
 Divi’s Labs earns an Income of Rs.218 crores in Q1
 Divi’s Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus
 Divi’s Labs PAT for 9 months
grows by 21% to Rs.309 crores
 Divi’s Labs PAT for Q2
grows by 49% to Rs.135 crores
 Divi’s Labs PAT for Q1
grows by 45% to Rs.94 crores
 Divi’s Labs PAT for FY08
grows by 87% to Rs.348 crores
 Divi’s Labs PAT for Q3
grows by 216% to Rs.99 crores
 Divi’s Labs PAT for Q2
grows by 204% to Rs.91 crores
 Divi’s Labs PAT for Q1
grows by 153% to Rs.65 crores
 Divi’s Labs PAT for FY07
grows by 167% to Rs.186 crores
 Divi’s Labs Q3 total income
 grows by 38% to Rs.152 crores
 Divis successful US-FDA
 inspection for Unit II
 Divi’s Labs Q2 total income
 grows by 97% to Rs.165 crores.
 Divi's Labs Q1 total income
 grows by 142% at Rs.165
 crores
 Divi's Laboratories earns
a net of 70 crores on an income
of Rs.392 crores in FY06
 Divi's gets nod for pharma SEZ
 Divis Laboratories earns a
 PBT of Rs.43 Crores in
 First-Half of FY06
 Divis Laboratories earns a
 total income of Rs.68
 Crores in Q1 of FY06
 Divis Laboratories earns a
 total income of Rs.365
 Crores in FY05
 Divis Laboratories earns a
 Net of Rs.105 Crores in Q3
 Divis Laboratories earns a
 PBT of Rs.45 Crores in
 First-Half of FY05
 Divis Laboratories earns a
 Net of Rs.14 Crores in Q1
Unit 1 | Hyderabad

Developed on a 500 acre site the Divis Hyderabad manufacturing facility comprises of 13 production buildings Pilot Plant and a kilo lab. The plant consists of around 314 reactors totalling a capacity of 1293 m3.

The production buildings have clearly defined finished product areas for APIs with clean air, purified water systems that operate under full cGMP as per US-FDA guidelines.

The facility was successfully inspected by US-FDA in Feb, 2008(which itself was a third inspection; the first two are in Sept 2000 and April 2004).

The Hyderabad facility has been certified for the following management systems.

ISO 9001 certified for its Quality systems.
ISO 14001 certified for its Environment Management.
OHSAS-18001 certification for its Occupational Health and Safety systems.

There are special production blocks to handle Corrosive, Cyanation, Hydrogenation, Bromination, Nitration reactions and high vacuum distillations. The plant also has services that include cooling with liquid nitrogen, brine, cool water, heating with thermal oil or steam, 100% standby power, warehouses & bulk solvent storage tank farms.

Process R&D has state of art equipment like automated multifunctional reaction units. Chemical hazard evaluation studies are carried and basis of safety is established for all the processes. Manufacturing activities are supported with well equipped Quality Control laboratories and an elaborate Quality Assurance and training centre. A Modernized Effluent Treatment Plant (ETP) with latest equipment like aerators, clarifiers, air blowers , Chemical process Hazard evaluation lab, GMP kilo lab facility , forced evaporation , reverse osmosis etc., handle liquid effluents and treats them chemically and biologically (aerobic & anaerobic) to the specified standards. Incineration is the process employed to treat organic solids, liquids and gases.

For more information you could have a look at the data sheets of the Divis Hyderabad facility given below.

top
Copyright © 2006, Divis Laboratories Ltd. All Rights Reserved     Web design london